166 related articles for article (PubMed ID: 20142249)
41. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C; Brisson J; Bérubé S; Pollak M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
[TBL] [Abstract][Full Text] [Related]
42. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
[TBL] [Abstract][Full Text] [Related]
43. Genetic variants of human UGT1A3: functional characterization and frequency distribution in a Chinese Han population.
Chen Y; Chen S; Li X; Wang X; Zeng S
Drug Metab Dispos; 2006 Sep; 34(9):1462-7. PubMed ID: 16738032
[TBL] [Abstract][Full Text] [Related]
44. Adolescent caffeine consumption and mammographic breast density in premenopausal women.
Yaghjyan L; Colditz G; Rosner B; Rich S; Egan K; Tamimi RM
Eur J Nutr; 2020 Jun; 59(4):1633-1639. PubMed ID: 31152213
[TBL] [Abstract][Full Text] [Related]
45. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome.
Peters WH; te Morsche RH; Roelofs HM
J Hepatol; 2003 Jan; 38(1):3-8. PubMed ID: 12480553
[TBL] [Abstract][Full Text] [Related]
46. Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.
Burchell B; Coughtrie MW
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):739-47. PubMed ID: 9255555
[TBL] [Abstract][Full Text] [Related]
47. Adiposity during early adulthood, changes in adiposity during adulthood, attained adiposity, and mammographic density among premenopausal women.
Alimujiang A; Appleton C; Colditz GA; Toriola AT
Breast Cancer Res Treat; 2017 Nov; 166(1):197-206. PubMed ID: 28702890
[TBL] [Abstract][Full Text] [Related]
48. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
[TBL] [Abstract][Full Text] [Related]
49. Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver.
Li Y; Buckley D; Wang S; Klaassen CD; Zhong XB
Drug Metab Dispos; 2009 Sep; 37(9):1978-86. PubMed ID: 19541828
[TBL] [Abstract][Full Text] [Related]
50. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
51. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
[TBL] [Abstract][Full Text] [Related]
52. Breast cancer susceptibility loci and mammographic density.
Tamimi RM; Cox D; Kraft P; Colditz GA; Hankinson SE; Hunter DJ
Breast Cancer Res; 2008; 10(4):R66. PubMed ID: 18681954
[TBL] [Abstract][Full Text] [Related]
53. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
[TBL] [Abstract][Full Text] [Related]
54. Adolescent fiber intake and mammographic breast density in premenopausal women.
Yaghjyan L; Ghita GL; Rosner B; Farvid M; Bertrand KA; Tamimi RM
Breast Cancer Res; 2016 Aug; 18(1):85. PubMed ID: 27520794
[TBL] [Abstract][Full Text] [Related]
55. An investigation of mammographic density and gene variants in healthy women.
Maskarinec G; Lurie G; Williams AE; Le Marchand L
Int J Cancer; 2004 Nov; 112(4):683-8. PubMed ID: 15382051
[TBL] [Abstract][Full Text] [Related]
56. Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases.
Turgeon D; Chouinard S; Belanger P; Picard S; Labbe JF; Borgeat P; Belanger A
J Lipid Res; 2003 Jun; 44(6):1182-91. PubMed ID: 12639971
[TBL] [Abstract][Full Text] [Related]
57. [Review on gene polymorphisms of UDP-glucuronosyltransferases and genetic susceptibility of cancer].
Wang Y; Zheng Y
Wei Sheng Yan Jiu; 2008 Sep; 37(5):629-32. PubMed ID: 19069670
[TBL] [Abstract][Full Text] [Related]
58. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
59. Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7.
Cheng Z; Rios GR; King CD; Coffman BL; Green MD; Mojarrabi B; Mackenzie PI; Tephly TR
Toxicol Sci; 1998 Sep; 45(1):52-7. PubMed ID: 9848110
[TBL] [Abstract][Full Text] [Related]
60. In vitro phase II metabolism of xanthohumol by human UDP-glucuronosyltransferases and sulfotransferases.
Ruefer CE; Gerhäuser C; Frank N; Becker H; Kulling SE
Mol Nutr Food Res; 2005 Sep; 49(9):851-6. PubMed ID: 16092069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
